Table 5.
Baseline, surgery and anaesthetic variables
| Variable | Robenacoxib (s.c. + oral) | Meloxicam s.c. + placebo oral | Total | P value |
|---|---|---|---|---|
| Total | 101 | 46 | 147 | |
| Age | 3.8 (4.1) | 2.9 (3.1) | 3.5 (3.8) | 0.075 |
| Body weight | 4.0 (1.0) | 3.8 (1.0) | 3.9 (1.0) | 0.26 |
| Sex and neutered status | ||||
| Male not neutered | 22 (22%) | 16 (35%) | 38 (26%) | 0.19 |
| Female not neutered | 12 (12%) | 8 (17%) | 20 (14%) | |
| Male neutered | 38 (38%) | 15 (33%) | 53 (36%) | |
| Female neutered | 29 (29%) | 7 (15%) | 36 (24%) | |
| Breed | ||||
| Burmese | 1 (1%) | 0 (0%) | 1 (1%) | 0.37 |
| Crossbred | 3 (3%) | 0 (0%) | 3 (2%) | |
| Domestic long hair | 5 (5%) | 0 (0%) | 5 (3%) | |
| Domestic short hair | 33 (33%) | 15 (33%) | 48 (33%) | |
| European | 57 (56%) | 29 (63%) | 86 (59%) | |
| Persian | 1 (1%) | 0 (0%) | 1 (1%) | |
| Siamese | 1 (1%) | 2 (4%) | 3 (2%) | |
| Baseline clinician scores | ||||
| Global investigator score | 3.1 (1.9) | 3.5 (2.3) | 3.2 (2.0) | 0.50 |
| Pain at palpation/manipulation | 1.5 (0.8) | 1.6 (0.8) | 1.5 (0.8) | 0.44 |
| Expected duration of surgery (hours) | ||||
| <60 min | 71 (70%) | 30 (65%) | 101 (69%) | 0.57 |
| >60 min | 30 (30%) | 16 (35%) | 46 (31%) | |
| Effective duration of surgery (hours) | 53.0 (38.8) | 57.9 (39.2) | 54.6 (38.8) | 0.41 |
| Effective duration of intubation | 80.4 (48.5) | 79.5 (50.0) | 80.2 (48.8) | 0.82 |
| Type of surgery | ||||
| Fracture, internal repair | 49 (49%) | 26 (57%) | 75 (51%) | 0.38 |
| Fracture, no internal repair | 1 (1%) | 0 (0%) | 1 (1%) | 1.0 |
| Hip surgery | 10 (10%) | 4 (9%) | 14 (10%) | 1.0 |
| Amputation, limb | 6 (6%) | 0 (0%) | 6 (4%) | 0.18 |
| Amputation, tail or phalanx | 6 (6%) | 4 (9%) | 10 (7%) | 0.73 |
| Joint surgery | 13 (13%) | 6 (13%) | 19 (13%) | 1.0 |
| Removal of osteosynthesis material | 13 (13%) | 3 (7%) | 16 (11%) | 0.28 |
| Miscellaneous | 2 (2%) | 2 (4%) | 4 (3%) | 0.59 |
| Combinations | 1 (1%) | 1 (2%) | 2 (1%) | 1.0 |
| Substances used in anaesthesia | ||||
| Acepromazine | 22 (22%) | 12 (26%) | 34 (23%) | 0.67 |
| Butorphanol | 33 (33%) | 15 (33%) | 48 (33%) | 1.0 |
| Diazepam | 6 (6%) | 4 (9%) | 10 (7%) | 0.73 |
| Ketamine | 57 (56%) | 28 (61%) | 85 (58%) | 0.72 |
| Medetomidine | 54 (53%) | 17 (37%) | 71 (48%) | 0.076 |
| Medetomidine/acepromazine | 0 (0%) | 1 (2%) | 1 (1%) | 0.31 |
| Propofol | 33 (33%) | 12 (26%) | 45 (31%) | 0.450 |
| Thiopental | 5 (5%) | 3 (7%) | 8 (5%) | 1.0 |
| Tiletamine/zolazepam | 7 (7%) | 2 (4%) | 9 (6%) | 0.72 |
| Xylazine | 18 (18%) | 11 (24%) | 29 (20%) | 0.50 |
s.c.: subcutaneous.
Data are mean (SD) or number of cats (%).